An ultrastructural and systemic analysis of glycosaminoglycans in thyroid-associated ophthalmopathy

Eye

Volumn 12, Issue 2, 1998, Pages 237-244

  Pappa, Anastasia ^a,b   Jackson, Peter ^c   Stone, Janet ^d   Munro, Peter ^b   Fells, Peter ^a   Pennock, Charles ^d   Lightman, Susan ^a,b  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d ST MICHAEL'S HOSPITAL   (United Kingdom)

Author keywords

Autoimmunity; Glycosaminoglycans (GAGS); Hyaluronan (HA); Immunogold; Thyroid associated ophthalmopathy (TAO); Transmission electron microscopy (TEM)

Indexed keywords

CARBAZOLE DERIVATIVE; CHONDROITIN SULFATE; COLLAGEN FIBER; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEXURONIC ACID; HYALURONIC ACID; TANNIN;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROPHORESIS; EXTRAOCULAR MUSCLE; EYE DISEASE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOGOLD STAINING; MALE; MUSCLE BIOPSY; PHOTOMETRY; RADIOIMMUNOASSAY; THYROID DISEASE; TRANSMISSION ELECTRON MICROSCOPY; URINARY EXCRETION; URINE LEVEL;

EID: 0031778155     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/eye.1998.57     Document Type: Article

References (29)

1. Fells P. Thyroid-associated eye disease: clinical management. Lancet 1991;338:29-32.
2. Jacobson DH, Gorman CA. Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis, and treatment. Endocr Rev 1984;5:200-20.
3. Wall JR, Salvi M, Bernard NF, Boucher A, Haegert D. Thyroid-associated ophthalmopathy: a model for the association of organ-specific autoimmune disorders. Immunol Today 1991;12:150-3.
4. Weetman AP. Thyroid-associated eye disease: pathophysiology. Lancet 1991;338:25-8.
5. Bahn RS, Heufelder AE. Pathogenesis of Graves' ophthalmopathy. N Engl J Med 1993;329:1468-75.
6. Perros P, Kendall-Taylor P. Thyroid-associated ophthalmopathy: pathogenesis and clinical management. Baillieres Clin Endocrinol Metab 1995;9:115-35.
7. Sridama V, de Groot LJ. Treatment of Graves' disease and the course of ophthalmopathy. Am J Med 1989;87:70-3.
8. Hufnagel TJ, Hickey WF, Cobbs NH, Jakobiec FA, Iwamoto T, Eagle RC. Immunohistochemical and ultrastrucrural studies on the exenterated orbital tissues of a patient with Graves' disease. Ophthalmology 1984;91:1411-9.
9. Weetman AP, Cohen S, Gatter KC, Fells P, Shine B. Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy. Clin Exp Immunol 1989;75:222-7.
10. Hiromatsu Y, Tanaka K, Ishisaka N, et al. Human histocompatibility leukocyte antigen-DR and heat shock protein-70 expression in eye muscle tissue in thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 1995;80:685-91.
11. Kroll AJ, Kuwabara T. Dysthyroid ocular myopathy: anatomy, histology, and electron microscopy. Arch Ophthaimol 1966;76:244-57.
12. Riley FC. Orbital pathology in Graves' disease. Mayo Clin Proc 1972;47:975-9.
13. Tallstedt L, Norberg R. Immunohistochemical staining of normal and Graves' extraocular muscle. Invest Ophthalmol Vis Sci 1988;29:175-84.
14. Campbell RJ. Immunology of Graves' ophthalmopathy: retrobulbar histology and histochemistry. Acta Endocrinol (Copenh) 1989;121 (Suppl 2): 9-16.
15. Scott JE. Supramolecular organization of extracellular matrix glycosaminoglycans, in vitro and in the tissues. FASEB J 1992;6:2639-45.
16. Kahaly G, Schuler M, Sewell AC, Bernhard G, Beyer J, Krause U. Urinary glycosaminoglycans in Graves' ophthalmopathy. Clin Endocrinol 1990;33:35-44.
17. Kahaly G, Hansen C, Beyer J, Winand R. Plasma glycosaminoglycans in endocrine ophthalmopathy. J Endocrinol Invest 1994;17:45-50.
18. Imai Y, Odajima R, Shimizu T, Shishiba Y. Serum hyaluronan concentration determined by radiometric assay in patients with pretibial myxedema and Graves' ophthalmopathy. Endocrinol Jpn 1990;37:749-52.
19. Robertson D, Monaghan P, Clarke C, Atherton AJ. An appraisal of low-temperature embedding by progressive lowering of temperature into Lowicryl HM20 for immunocytochemical studies. J Microsc 1992;168:85-100.
20. Engstrom-Laurent A, Laurent UBG, Lilja K, Laurent TC. Concentration of sodium hyaluronate in serum. Scand J Clin Lab Invest 1985;45:497-504.
21. Di Ferrante N. The measurement of urinary mucopolysaccharides. Anal Biochem 1967;21:98-106.
22. Pennock CA, Charles RG, Stansbie D. Glycosaminoglycan fractions in normal human urine. Ann Clin Biochem 1975;12:207-11.
23. Bitter T, Muir HM. A modified uronic acid carbazole reaction. Anal Biochem 1962;4:330-4.
24. Hopwood JJ, Harrison JR. High-resolution electrophoresis of urinary glycosaminoglycans: an improved screening test for the mucopolysaccharidoses. Anal Biochem 1982;119:120-7.
25. Fells P, Kousoulides L, Pappa A, Munro P, Lawson J. Extraocular muscle problems in thyroid eye disease. Eye 1994;8:497-505.
26. Imai Y, Odajima R, Inoue Y, Shishiba Y. Effect of growth factors on hyaluronan and proteoglycan synthesis by rerroocular tissue fibroblasts of Graves' ophthalmopathy in culture. Acta Endocrinol (Copenh) 1992;126:541-52.
27. Engstrom-Laurent A, Hallgren R. Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis 1985;44:83-8.
28. Levesque H, Delpech B, Le Loet X, Deshayes P. Serum hyaluronate in rheumatoid arthritis: study of affino-immunoenzymatic assay. Br J Rheumatol 1988;27:445-9.
29. Winand RJ. Increased urinary excretion of acidic mucopolysaccharides in exophthalmos. J Clin Invest 1968;47:2563-8.